Technology explainer
How Plasmid-DNA Immunotherapy Delivers Genetic Instructions
Engineered plasmids carry genes into cells, which briefly produce selected antigens or immune signals that train the immune system without using a replicating pathogen.
Plasmids are small circular DNA molecules that can be engineered to carry genes for a therapeutic antigen or immune signal. After delivery into cells, cellular machinery reads those genes and produces the encoded proteins.
Why electroporation is used
DNA does not easily cross cell membranes. Brief electrical pulses can create temporary pores that increase uptake near the injection site. The membrane then closes again.
How immunity develops
Cells produce the encoded antigen, and immune cells learn to recognize it. A second plasmid may encode an immune-stimulating molecule that strengthens or shapes the response.
What the platform does not guarantee
Successful protein production does not guarantee durable clinical benefit. Dose, delivery, immune variability and safety must be established in trials, and accelerated approvals may require confirmatory studies.
First appeared in
FDA Approves the First US Plasmid-DNA Immunotherapy
